Products

Regulations

Japanese Pharmacopeia

Japanese Pharmacopeia

Target Compounds  Phase  Column Dimension  Recommend Column Cat.No.
Acetohexamide InertCap 1 0.53 mm I.D. x 30 m df=1.50 μm 1010-11446
Ethanol
Dehydrated Ethanol Ethanol for Disinfection
InertCap 624
Note: If necessary, identify suitable analysis conditions with stationary phase which is different from polarity of benzene.
0.32 mm I.D. x 30 m df=1.80 μm 1010-14747
Epirubicin Hydrochloride InertCap WAX InertCap Pure-WAX 0.53 mm I.D. x 30 m df=1.00 μm
0.53 mm I.D. x 30 m df=1.00 μm
1010-67445
1010-68445
Glycerol Concentrated Glycerin InertCap 1701 0.32 mm I.D. x 30 m df=1.00 μm 1010-61245
Wood Creosote
Purity test of Coal Creosote
InertCap 5 InertCap 5MS/NP InertCap 5MS/Sil 0.25 mm I.D. x 30 m df=0.25 μm
0.25 mm I.D. x 30 m df=0.25 μm
0.25 mm I.D. x 30 m df=0.25 μm
1010-18142
1010-18642
1010-15142
Wood Creosote
Purity test of Acenaphthene
InertCap 1 0.25 mm I.D. x 60 m df=0.25 μm
0.25 mm I.D. x 60 m df=0.40 μm
1010-11162
1010-11163
Colchicine InertCap Pure-WAX 0.53 mm I.D. x 30 m df=1.00 μm 1010-68445
Magnesium Stearate InertCap WAX-HT InertCap Pure-WAX InertCap WAX 0.32 mm I.D. x 30 m df=0.50 μm
0.32 mm I.D. x 30 m df=0.50 μm
0.32 mm I.D. x 30 m df=0.50 μm
1010-68644
1010-68244
1010-67244
Sevoflurane InertCap 624 0.32 mm I.D. x 30 m df=1.80 μm 1010-14747
Teceleukin  (Gene Recombination) G-300 1.20 mm I.D. x 40 m df=1.00 μm Please contact
Panipenem G-950 1.20 mm I.D. x 40 m df=25 μm Please contact
Benzyl Alcohol InertCap Pure-WAX InertCap WAX 0.32 mm I.D. x 30 m df=0.50 μm
0.32 mm I.D. x 30 m df=0.50 μm
1010-68244
1010-67244
Labetalol Hydrochloride InertCap 1 0.53 mm I.D. x 30 m df=5.00 μm 1010-11449
Iohexol
(Supplement I to the Japanese Pharmacopoeia,16th Edition)
InertCap 5 0.25 mm I.D. x 30 m df=0.25 μm 1010-18142
Clomiophene Citrate (Supplement I to the Japanese Pharmacopoeia,16th Edition) InertCap 1 0.25 mm I.D. x 15 m df=0.10 μm 1010-11120
Anhydrous Lactose (Supplement I to the Japanese Pharmacopoeia,16th Edition) InertCap 5
Medium polar - deactivated fused silica tube
0.25 mm I.D. x 15 m df=0.25 μm
0.53 mm I.D. x 2 m
1010-18122
1010-36782
Bupivacaine Hydrochloride Hydrate (Supplement I to the Japanese Pharmacopoeia,16th Edition) InertCap 5 0.32 mm I.D. x 30 m df=0.25 μm 1010-18242
Lenograstim (Gene Recombination) (Supplement I to the Japanese Pharmacopoeia,16th Edition) InertCap 1701 0.25 mm I.D. x 30 m df=0.25 μm 1010-61142

5.01 Crude Drugs Test

Description
(Japanese Pharmacopoeia,16th Edition)
Application Column
Dimension
Recommend Column Cat.No.
Polygala root, polygala root powder, Licorice, Licorice powder,
Chinese Cinnamon, Chinese Cinnamon powder, Red Ginseng,
Asiasarum Root, Cornus Fruit, Senna Leaf, Senna Leaf Powder,
Perilla Herb, Jujube, Citrus Unshiu Peel, Carrot, Carrot Powder,
Eriobotryae Folium, Moutan Bark, Moutan Bark Powder.
InertCap 1701
0.32 mm I.D.×30 m df=0.25 μm
0.32 mm I.D.×30 m df=0.50 μm
0.32 mm I.D.×30 m df=1.00 μm
1010-61242
1010-61244
1010-61245

7.02 Test Methods for Plastic Containers

Description
(Japanese Pharmacopoeia,16th Edition)
Phase
Column Dimensions
Recommend Column Cat.No.
Polyvinyl chloride containers for aqueous injection
CP-Pora BOND Q
0.25 mm I.D.×25 m df=3.00 μm
1010-77348

9.41 Reagents, Test Solutions

Description
(Japanese Pharmacopoeia,16th Edition)
Phase
Column Dimensions
Recommend Column Cat.No.
α-BHC (α-Hexachlorocyclohexane)
InertCap 1701
0.32 mm I.D.×30 m df=0.25 μm
0.32 mm I.D.×30 m df=0.50 μm
0.32 mm I.D.×30 m df=1.00 μm
1010-61242
1010-61244
1010-61245
p,p’-DDD (2,2-bis (4-chlorophenyl)-1,1-dichloroethane)
InertCap 1701
0.32 mm I.D.×30 m df=0.25 μm
0.32 mm I.D.×30 m df=0.50 μm
0.32 mm I.D.×30 m df=1.00 μm
1010-61242
1010-61244
1010-61245
Guaiacol, for quantitative determination
InertCap 1
0.25 mm I.D.×60 m df=0.25 μm
0.25 mm I.D.×60 m df=0.40 μm
1010-11162
1010-11163
Diethyl Ether, for purity test of Crude Drugs
InertCap 1701
0.32 mm I.D.×30 m df=0.25 μm
0.32 mm I.D.×30 m df=0.50 μm
0.32 mm I.D.×30 m df=1.00 μm
1010-61242
1010-61244
1010-61245
Dibenz[a,h] anthracene
InertCap 5
InertCap 5MS/NP
InertCap 5MS/Sil
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
1010-18142
1010-18642
1010-15142
 
N,N-dimethylacetamide
InertCap Pure-WAX
InertCap WAX
0.25 mm I.D.×30 m df=0.50 μm
0.25 mm I.D.×30 m df=0.50 μm
1010-68144
1010-67144
Cilastatinammonium, for quantitative determination
InertCap 5
0.53 mm I.D.×30 m df=5.00 μm
1010-18449
1-vinyl-2-Pyrrolidone
InertCap Pure-WAX
InertCap WAX
InertCap WAX-HT
0.53 mm I.D.×30 m df=1.00 μm
0.53 mm I.D.×30 m df=1.00 μm
0.53 mm I.D.×30 m df=1.00 μm
1010-68445
1010-67445
1010-68745
Hexane, for purity test of Crude Drugs
InertCap 1701
0.32 mm I.D.×30 m df=0.25 μm
0.32 mm I.D.×30 m df=0.50 μm
0.32 mm I.D.×30 m df=1.00 μm
1010-61242
1010-61244
1010-61245
Benz[a] anthracene
InertCap 5
InertCap 5MS/NP
InertCap 5MS/Sil
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
1010-18142
1010-18642
1010-15142
Benzo[a] Pyrene
InertCap 5
InertCap 5MS/NP
InertCap 5MS/Sil
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
1010-18142
1010-18642
1010-15142
2-methoxy-4- methylphenol
InertCap 1
0.25 mm I.D.×60 m df=0.25 μm
0.25 mm I.D.×60 m df=0.40 μm
1010-11162
1010-11163
3-chloro-1,2-propanediol
(Supplement I to the Japanese Pharmacopoeia,16th Edition)
InertCap 5
0.25 mm I.D.×30 m df=0.25 μm
1010-18142
Ethyl formate
(Supplement I to the Japanese Pharmacopoeia,16th Edition)
InertCap Pure-WAX
InertCap WAX
InertCap WAX-HT
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
0.25 mm I.D.×30 m df=0.25 μm
1010-68142
1010-67142
1010-68542

Reference Information

Description
(Japanese Pharmacopoeia,16th Edition)
Phase
Column Dimensions
Recommend Column Cat.No.
Physics and Chemistry Guideline for Residual Solvents and Method
for the Residual Solvents Test
(ⅰ)InertCap 624
0.53 mm I.D.×30 m df=3.00 μm
0.32 mm I.D.×30 m df=1.80 μm
1010-14948
1010-14747
(ⅱ)InertCap Pure-WAX
0.32 mm I.D.×30 m df=0.25 μm
1010-68242
(ⅲ)InertCap 5
0.53 mm I.D.×30 m df=5.00 μm
1010-18449